PLEASANTON, Calif., July 25 Thoratec Corporation(Nasdaq: THOR) a world leader in device-based mechanical circulatory supporttherapies to save, support and restore failing hearts, today announced that itwill report its operating results for the second quarter and first six monthsof fiscal 2008 on Thursday, July 31.
The company will hold a conference call to discuss its financial resultsand operating activities to all interested parties at 1:30 p.m., PacificDaylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 31, hosted byGary F. Burbach, president and chief executive officer, and David Smith,executive vice president and chief financial officer.
The teleconference can be accessed by calling (913) 312-0379, passcode4566478. Please dial in 10-15 minutes prior to the beginning of the call. Thewebcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1890100 or athttp://www.thoratec.com
A replay of the conference call will be available through Thursday,August 7, via http://www.thoratec.com or by telephone at (719) 457-0820,passcode 4566478.
Thoratec Corporation is a world leader in therapies to addressadvanced-stage heart failure. The company's product lines include theThoratec(R) VAD (Ventricular Assist Device) and HeartMate (R) LVAS (LeftVentricular Assist System) with nearly 12,000 devices implanted in patientssuffering from heart failure. Additionally, its International TechnidyneCorporation (ITC) division supplies point-of-care blood testing and skinincision products. Thoratec is headquartered in Pleasanton, California. Formore information, visit the company's web sites at http://www.thoratec.com orhttp://www.itcmed.com
SOURCE Thoratec Corporation